Stocks That Hit 52-Week Lows On Wednesday
Before 10 a.m. ET on Wednesday, 8 companies hit new 52-week lows.
PLX: 1Q:21 Results & Next Steps
By John Vandermosten, CFA
NYSE:PLX
READ THE FULL PLX RESEARCH REPORT
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 13)
Protalix BioTherapeutics Q1 EPS $(0.14) Beats $(0.17) Estimate, Sales $11.32M Beat $10.95M Estimate
Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.17) by 17.65 percent. This is a 240 percent decrease over earnings of $0.10 per share
Earnings Scheduled For May 14, 2021
Companies Reporting Before The Bell
• Sogou (NYSE:SOGO) is projected to report earnings for its first quarter.
• Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its first quarter.
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May.
82 Biggest Movers From Yesterday
Gainers Genprex Inc (NASDAQ:GNPX) shares jumped 219.4% to close at $1.15 on Tuesday after the company announced that…